CG0009, a Novel Glycogen Synthase Kinase 3 Inhibitor, Induces Cell Death through Cyclin D1 Depletion in Breast Cancer Cells

• Hyun Mi Kim,

  Affiliations Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Institute for Innovative Cancer Research, Asan Medical Center, Seoul, Korea

  ⨯
• Choung-Soo Kim,

  Affiliations Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Institute for Innovative Cancer Research, Asan Medical Center, Seoul, Korea

  ⨯
• Je-Hwan Lee,

  Affiliations Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Institute for Innovative Cancer Research, Asan Medical Center, Seoul, Korea

  ⨯
• Se Jin Jang,

  Affiliations Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Institute for Innovative Cancer Research, Asan Medical Center, Seoul, Korea

  ⨯
• Jung Jin Hwang,

  Affiliations Asan Institute for Life Science, Asan Medical Center, Seoul, Korea, Institute for Innovative Cancer Research, Asan Medical Center, Seoul, Korea

  ⨯
• Seonggu Ro,

  Affiliation CrystalGenomics Inc. Seoul, Korea

  ⨯
• Jene Choi

  * E-mail: jenec@amc.seoul.kr

  Affiliations Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Institute for Innovative Cancer Research, Asan Medical Center, Seoul, Korea

  ⨯